NEW YORK (GenomeWeb) – CFD Research Corporation (CFDRC) has acquired the microbiome-based drug discovery division of iXpressGenes (iXG) for an undisclosed amount.

CFDRC and iXpressGenes are both associate companies of the HudsonAlpha Institute for Biotechnology in Huntsville, Alabama.

As part of the acquisition, CFDRC obtained iXG's high-throughput antimicrobial discovery platform, EMAD (extremophilic microbiome antimicrobial discovery), and all key personnel associated with the division, the companies said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.